Eyevensys Enters Collaboration with Phillips-Medisize and Minnetronix Medical
Retrieved on:
Monday, September 27, 2021
Technology, Medical Devices, Infectious Diseases, Genetics, Clinical Trials, Software, Biotechnology, Hardware, Health, Optical, Geographic atrophy, Business development, Ciliary muscle, Diffuse axonal injury, Neuro, Pulse generator, Solution, European Medicines Agency, IgG4-related ophthalmic disease, Inflammation, DNA, Device, AMD, Patient, Diabetic retinopathy, Electroporation, NIU, Pulse, Business, Eye, Risk management, Plasmid, VEGF, Retinitis pigmentosa, History, Glaucoma, RF, EMA, Pharmaceutical industry, Vaccine, Medical device, Eyevensys, Minnetronix Medical, EYEVENSYS, MINNETRONIX MEDICAL
Alan Wirbisky, Director of Device Development at Eyevensys, said: The opportunity to collaborate with both Minnetronix Medical and Phillips-Medisize is incredibly significant for Eyevensys given the capabilities and experience that the two companies possess.
Key Points:
- Alan Wirbisky, Director of Device Development at Eyevensys, said: The opportunity to collaborate with both Minnetronix Medical and Phillips-Medisize is incredibly significant for Eyevensys given the capabilities and experience that the two companies possess.
- During our 25 year history, we have successfully partnered with many medical startups like Eyevensys to navigate the pitfalls of electromechanical medical device development.
- Since 1996, Minnetronix Medical has accelerated medical device breakthroughs via design, development and manufacturing services for companies around the world.
- Minnetronix Medical is based in St. Paul, Minn. More information can be found on the Minnetronix website, by calling 651-917-4060 or emailing [email protected] .